Topol and Teirstein: The Click and Rub Show

View all posts »

Episode #3: Percutaneous aortic-valve procedures

Jul 29, 2009 11:30 EDT


From fiction to fact: in the near future most aortic-valve procedures will be percutaneous. Join Drs Topol and Teirstein for a light hearted discussion that—while also evoking harpoons and pulp fiction—illustrates why this procedure is transformational for patient outcomes, a welcome collaboration between interventionalist and vascular surgeon, and the path forward for aortic-valve replacement.

 





« Previous Post
Episode #4: Why is medicine resistant to change?
Oct 29, 2009 13:30 EDT Next post »
Episode #2: Dissecting "the cost conundrum": McAllen, Gawande, Obama, and healthcare reform in the US
Jun 29, 2009 15:13 EDT



Your comments
Episode #3: Percutaneous aortic-valve procedures
# 1 of 1
January 22, 2011 05:10 (EST)
manu
Percutaneous Aortic Valve Replacement (PAVR)

Percutaneous Aortic Valve Replacement (PAVR) is a new technology used for treatment of aortic valve disease. There are cases where the heart’s aortic valve becomes narrowed thus preventing it from opening properly. This in turn blocks the blood flow from the left lower chamber of the heart to the aorta. In order to maintain the normal blood flow percutaneous aortic valve replacement is done. 

http://www.heart-consult.com/articles/percutaneous-aortic-valve-replacement-pavr

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access    
About the Click and Rub Show
theheart.org brings you a freewheeling and unconventional exchange on the latest cardiology news and events through the eyes of thought leaders Drs Eric Topol and Paul Teirstein from Scripps Translational Research Institute.

We value the diverse opinions of our readership (that includes you!) -- share your thoughts by writing them in the comments box at left and stay tuned for new shows, posted on a monthly basis.